Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II Trial of Dasatinib in Advanced Sarcomas

Trial Profile

A Phase II Trial of Dasatinib in Advanced Sarcomas

Phase of Trial: Phase II

Latest Information Update: 29 Nov 2018

At a glance

  • Drugs Dasatinib (Primary)
  • Indications Alveolar soft part sarcoma; Chondrosarcoma; Chordoma; Ewing's sarcoma; Gastrointestinal stromal tumours; Leiomyosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Nerve sheath neoplasms; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Soft tissue sarcoma; Solitary-fibrous-tumour
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 20 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 May 2017.
    • 12 Oct 2016 Planned End Date changed from 1 Jun 2015 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top